Publication

Article

Pharmacy Practice in Focus: Health Systems
September 2024
Volume 13
Issue 5

Celebrating 25 Years of Partnership and Innovation in Health Care

MJH Life Sciences is celebrating its 25th anniversary.

Health care professional and elderly patient -- Image credit: Rido | stock.adobe.com

Image credit: Rido | stock.adobe.com

As MJH Life Sciences celebrate our 25th anniversary, I wanted to take a moment to express my deepest gratitude for your partnership in our shared goal of improving health care.

Reflecting on the changes from the past 25 years, I note that the innovation in health care has been nothing short of miraculous. Together we have witnessed major advances that have cured some diseases and made others that were terminal into chronic conditions. We have also navigated economic fluctuations and the introduction of new laws, policies, and payment models that have significantly shifted the reimbursement landscape. Throughout these changes and into the future, MJH is committed to providing high-quality information and education.

Starting with a single brand and quickly growing across key areas, we have launched thousands of video programs, developed cutting-edge conferences, and held thousands of virtual and live events. Throughout this growth we have remained committed not only to speed and quality but to you, as your knowledge and expertise have made many of these achievements possible. I want to thank you for sharing your expert insight to help keep other health care professionals up to date on the latest research and advances.

The driving force behind our continued evolution these past 25 years is our passion for improving health care, and we thank you for joining us on this journey. We look forward to continuing to expand our reach to keep delivering high-quality expert knowledge, insights, and research for the next 25 years and more.

Thank you for your partnership as we seek to improve health care together. I look forward to collaborating well into the future.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs